Low Dose Naltrexone
Susie Corcoran Susie Corcoran

Low Dose Naltrexone

LDN is a competitive opioid receptor antagonist. At higher doses, (generally used for addiction), naltrexone blocks the effects of both the endogenous (bodies own) opioids, and pharmaceutical opioids. At lower doses, (a 10th or less of the standard dose), LDN causes microglial cells in the nervous system to ‘up-regulate’ (meaning to boost up) opioid receptors, and there are a wide range of cells in the body that have opiod receptors. In addition, LDN helps to regulate immune system functioning by decreasing and regulating inflammatory mediators that cause muscle and soft tissue pain. 

If you are interested in exploring options for this, send us your information and we can get you scheduled.

Read More
Estrogen, Hormone Replacement Therapy and Mitochondrial Action
Susie Corcoran Susie Corcoran

Estrogen, Hormone Replacement Therapy and Mitochondrial Action

Estrogen is a critical participant in in metabolic regulation. Clinical trials and animal studies have shown that reductions in  circulating estrogen causes swift changes in metabolism, fat distribution, and insulin function. The metabolic effects of estrogen are caused primarily by estrogen receptor-a on the distinct body systems’ cell. Research suggests that estrogen receptor-α elicits the metabolic effects of estrogen through mitochondrial mechanisms that regulate insulin signaling, and energetics.

Read More